Trials / Terminated
TerminatedNCT04796272
Role of Individualized Versus Traditional Exercise in Combating Fatigue
Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.
Detailed description
Chronic fatigue is a very common symptom reported (80%) by patients with multiple sclerosis (MS), regardless of the type of MS and level of disability. Despite the clinical importance of MS-related fatigue, pharmacological treatments remain quite ineffective in preventing or treating chronic fatigue. Recently, physical activity has proven to be an effective therapy with benefits on chronic fatigue as well as on different functions (muscular, cardiorespiratory, cognitive, etc.). Nevertheless, the effects of physical exercise may vary between MS patients, as MS is a heterogeneous disease and does not affect each individual in the same way. The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Adapted and individualized physical training program | Physical training program adapted and individualized according to each patient in this group |
| OTHER | traditional training program | Same training program for all patients in this group |
Timeline
- Start date
- 2021-04-02
- Primary completion
- 2022-02-23
- Completion
- 2022-06-30
- First posted
- 2021-03-12
- Last updated
- 2023-11-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04796272. Inclusion in this directory is not an endorsement.